IOBT Q4 2023 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$201,000

Operating Income

-$28M

Net Income

-$26M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$151M

Total Liabilities

$18M

Stockholders' Equity

$133M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$201,000	-$190,000	-5.8%
Operating Income	-$28M	-$20M	-38.2%
Net Income	-$26M	-$20M	-30.4%